Form 8-K - Current report:
SEC Accession No. 0001558370-24-009487
Filing Date
2024-06-26
Accepted
2024-06-26 08:00:16
Documents
18
Period of Report
2024-06-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K agrx-20240625x8k.htm   iXBRL 8-K 69417
2 EX-2.1 agrx-20240625xex2d1.htm EX-2.1 759619
3 EX-4.1 agrx-20240625xex4d1.htm EX-4.1 41836
4 EX-10.1 agrx-20240625xex10d1.htm EX-10.1 160941
5 EX-10.2 agrx-20240625xex10d2.htm EX-10.2 221916
6 EX-99.1 agrx-20240625xex99d1.htm EX-99.1 31798
  Complete submission text file 0001558370-24-009487.txt   1610822

Data Files

Seq Description Document Type Size
7 EX-101.SCH agrx-20240625.xsd EX-101.SCH 3435
8 EX-101.LAB agrx-20240625_lab.xml EX-101.LAB 14107
9 EX-101.PRE agrx-20240625_pre.xml EX-101.PRE 9014
21 EXTRACTED XBRL INSTANCE DOCUMENT agrx-20240625x8k_htm.xml XML 4311
Mailing Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635
Business Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635 609-683-1880
AGILE THERAPEUTICS INC (Filer) CIK: 0001261249 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36464 | Film No.: 241070647
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)